nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxaprozin—Nonsteroidal Anti-inflammatory Compounds—Acetylsalicylic acid—Kawasaki disease	0.507	1	CiPCiCtD
Oxaprozin—rheumatoid arthritis—Acetylsalicylic acid—Kawasaki disease	0.174	0.588	CpDpCtD
Oxaprozin—osteoarthritis—Acetylsalicylic acid—Kawasaki disease	0.122	0.412	CpDpCtD
Oxaprozin—PTGS2—Acetylsalicylic acid—Kawasaki disease	0.0782	0.458	CbGbCtD
Oxaprozin—PTGS1—Acetylsalicylic acid—Kawasaki disease	0.066	0.387	CbGbCtD
Oxaprozin—CYP2C9—Acetylsalicylic acid—Kawasaki disease	0.0266	0.156	CbGbCtD
Oxaprozin—Diuresis—Acetylsalicylic acid—Kawasaki disease	0.00284	0.11	CcSEcCtD
Oxaprozin—Kidney function abnormal—Acetylsalicylic acid—Kawasaki disease	0.00182	0.0704	CcSEcCtD
Oxaprozin—Peptic ulcer—Acetylsalicylic acid—Kawasaki disease	0.00132	0.0509	CcSEcCtD
Oxaprozin—Heartburn—Acetylsalicylic acid—Kawasaki disease	0.00128	0.0494	CcSEcCtD
Oxaprozin—Haematemesis—Acetylsalicylic acid—Kawasaki disease	0.00127	0.0489	CcSEcCtD
Oxaprozin—Ulcer—Acetylsalicylic acid—Kawasaki disease	0.000931	0.0359	CcSEcCtD
Oxaprozin—Hearing impaired—Acetylsalicylic acid—Kawasaki disease	0.000925	0.0357	CcSEcCtD
Oxaprozin—Melaena—Acetylsalicylic acid—Kawasaki disease	0.00086	0.0332	CcSEcCtD
Oxaprozin—Coma—Acetylsalicylic acid—Kawasaki disease	0.000804	0.0311	CcSEcCtD
Oxaprozin—Polyuria—Acetylsalicylic acid—Kawasaki disease	0.000728	0.0281	CcSEcCtD
Oxaprozin—Deafness—Acetylsalicylic acid—Kawasaki disease	0.000714	0.0276	CcSEcCtD
Oxaprozin—Vascular purpura—Acetylsalicylic acid—Kawasaki disease	0.000714	0.0276	CcSEcCtD
Oxaprozin—Renal impairment—Acetylsalicylic acid—Kawasaki disease	0.000672	0.0259	CcSEcCtD
Oxaprozin—Purpura—Acetylsalicylic acid—Kawasaki disease	0.000663	0.0256	CcSEcCtD
Oxaprozin—Gastrointestinal haemorrhage—Acetylsalicylic acid—Kawasaki disease	0.000639	0.0247	CcSEcCtD
Oxaprozin—Asthma—Acetylsalicylic acid—Kawasaki disease	0.000552	0.0213	CcSEcCtD
Oxaprozin—Drowsiness—Acetylsalicylic acid—Kawasaki disease	0.000492	0.019	CcSEcCtD
Oxaprozin—Haemoglobin—Acetylsalicylic acid—Kawasaki disease	0.000444	0.0172	CcSEcCtD
Oxaprozin—Haemorrhage—Acetylsalicylic acid—Kawasaki disease	0.000442	0.0171	CcSEcCtD
Oxaprozin—Tinnitus—Acetylsalicylic acid—Kawasaki disease	0.000412	0.0159	CcSEcCtD
Oxaprozin—Anaemia—Acetylsalicylic acid—Kawasaki disease	0.000356	0.0137	CcSEcCtD
Oxaprozin—Angioedema—Acetylsalicylic acid—Kawasaki disease	0.000352	0.0136	CcSEcCtD
Oxaprozin—Vertigo—Acetylsalicylic acid—Kawasaki disease	0.000346	0.0134	CcSEcCtD
Oxaprozin—Syncope—Acetylsalicylic acid—Kawasaki disease	0.000345	0.0133	CcSEcCtD
Oxaprozin—Leukopenia—Acetylsalicylic acid—Kawasaki disease	0.000344	0.0133	CcSEcCtD
Oxaprozin—Loss of consciousness—Acetylsalicylic acid—Kawasaki disease	0.000338	0.0131	CcSEcCtD
Oxaprozin—Convulsion—Acetylsalicylic acid—Kawasaki disease	0.000333	0.0129	CcSEcCtD
Oxaprozin—Hypertension—Acetylsalicylic acid—Kawasaki disease	0.000332	0.0128	CcSEcCtD
Oxaprozin—Confusional state—Acetylsalicylic acid—Kawasaki disease	0.000317	0.0122	CcSEcCtD
Oxaprozin—Anaphylactic shock—Acetylsalicylic acid—Kawasaki disease	0.000314	0.0121	CcSEcCtD
Oxaprozin—Shock—Acetylsalicylic acid—Kawasaki disease	0.000309	0.0119	CcSEcCtD
Oxaprozin—Thrombocytopenia—Acetylsalicylic acid—Kawasaki disease	0.000308	0.0119	CcSEcCtD
Oxaprozin—Tachycardia—Acetylsalicylic acid—Kawasaki disease	0.000307	0.0118	CcSEcCtD
Oxaprozin—Hyperhidrosis—Acetylsalicylic acid—Kawasaki disease	0.000304	0.0117	CcSEcCtD
Oxaprozin—Dyspnoea—Acetylsalicylic acid—Kawasaki disease	0.00028	0.0108	CcSEcCtD
Oxaprozin—Somnolence—Acetylsalicylic acid—Kawasaki disease	0.000279	0.0108	CcSEcCtD
Oxaprozin—Dyspepsia—Acetylsalicylic acid—Kawasaki disease	0.000276	0.0107	CcSEcCtD
Oxaprozin—Feeling abnormal—Acetylsalicylic acid—Kawasaki disease	0.000259	0.01	CcSEcCtD
Oxaprozin—Urticaria—Acetylsalicylic acid—Kawasaki disease	0.00025	0.00964	CcSEcCtD
Oxaprozin—Pruritus—Acetylsalicylic acid—Kawasaki disease	0.000222	0.00858	CcSEcCtD
Oxaprozin—Diarrhoea—Acetylsalicylic acid—Kawasaki disease	0.000215	0.0083	CcSEcCtD
Oxaprozin—Dizziness—Acetylsalicylic acid—Kawasaki disease	0.000208	0.00802	CcSEcCtD
Oxaprozin—Vomiting—Acetylsalicylic acid—Kawasaki disease	0.0002	0.00771	CcSEcCtD
Oxaprozin—Rash—Acetylsalicylic acid—Kawasaki disease	0.000198	0.00765	CcSEcCtD
Oxaprozin—Dermatitis—Acetylsalicylic acid—Kawasaki disease	0.000198	0.00764	CcSEcCtD
Oxaprozin—Nausea—Acetylsalicylic acid—Kawasaki disease	0.000187	0.00721	CcSEcCtD
Oxaprozin—PTGS1—artery—Kawasaki disease	7.34e-05	0.15	CbGeAlD
Oxaprozin—PTGS2—artery—Kawasaki disease	7.02e-05	0.143	CbGeAlD
Oxaprozin—PTGS1—endothelium—Kawasaki disease	6.2e-05	0.127	CbGeAlD
Oxaprozin—PTGS2—endothelium—Kawasaki disease	5.93e-05	0.121	CbGeAlD
Oxaprozin—PTGS2—gall bladder—Kawasaki disease	5.14e-05	0.105	CbGeAlD
Oxaprozin—PTGS1—myocardium—Kawasaki disease	3.87e-05	0.0792	CbGeAlD
Oxaprozin—CYP2C9—heart—Kawasaki disease	2.96e-05	0.0605	CbGeAlD
Oxaprozin—PTGS1—heart—Kawasaki disease	2.7e-05	0.0553	CbGeAlD
Oxaprozin—PTGS1—skin of body—Kawasaki disease	2.65e-05	0.0541	CbGeAlD
Oxaprozin—PTGS2—heart—Kawasaki disease	2.58e-05	0.0528	CbGeAlD
Oxaprozin—PTGS2—skin of body—Kawasaki disease	2.53e-05	0.0517	CbGeAlD
